Skip to content

Study on the Effectiveness of Varmam Therapy for Treating Knee Osteoarthritis

Efficacy of Varmam Therapy for the Management of Osteoarthritis (Knee Joint)- An Open Clinical Trial - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093896
Enrollment
100
Registered
2025-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of arthritis of one or both knee joints, pain, swelling, stiffness, crepitation, restricted movements of knee joint. Patients who are willing to undergo radiological investigation, laboratory investigations. Patients willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 160 days but can opt out of the trial of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: H/o Cardiac diseases H/o Rheumatoid arthritis H/o Pregnancy and lactation H/o Chronic kidney disease H/o Tuberculosis of knee H/o Septic arthritis H/o Gonococcal arthritis H/o Traumatic pain of knee joint H/o Patient with any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
PRIMARY OUTCOME To Assess the improvement of Santhuvatham (Osteo Arthritis?Knee joint) by reduce at least 2 or 3 scales from start to end of the study in KOO scale in the duration of 3 months (total number of sessions-36) in each patient, the assessment will be done in the duration period of 0,12th, 23rd, 36th day of sessionsTimepoint: PRIMARY OUTCOME To Assess the improvement of Santhuvatham (Osteo Arthritis?Knee joint) by reduce at least 2 or 3 scales from start to end of the study in KOO scale in the duration of 3 months (total number of sessions-36) in each patient, the assessment will be done in the duration period of 0,12th, 23rd, 36th day of sessions

Secondary

MeasureTime frame
SECONDARY OUTCOME To Assess the mental status before & after the varmam therapy management by Patient Health Questionnaire-9 [PHQ-9] & Brief Illness Perception Questionnaire [B-IPQ] in the duration of 3 months (Total number of sessions-36) in each patient. the assessment will be done in the duration period of 0,12th, 23rd, 36th day of sessions.Timepoint: SECONDARY OUTCOME To Assess the mental status before & after the varmam therapy management by Patient Health Questionnaire-9 [PHQ-9] & Brief Illness Perception Questionnaire [B-IPQ] in the duration of 3 months (Total number of sessions-36) in each patient. the assessment will be done in the duration period of 0,12th, 23rd, 36th day of sessions.

Countries

India

Contacts

Public ContactDr Bharathajothi P

Tamil University,Thanjavur

drbharathajothi@gmail.com9443797156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026